Show notes
In the Clinic episode aimed at doctors and nurses with an interest in cancer care. We discuss the INTERLACE trial in cervical cancer.
The INTERLACE trial led by Dr Mary McCormack was presented in ESMO 2023 and looks to shape oncological treatment of cervical cancer in the locally advanced setting.
We talk to Dr Gemma Eminowicz who has worked with Dr Mary McCormack over the last 10 years on the INTERLACE trial.
We discuss the 8% overall survival gain at 5 years from the addition of an extra 6 weeks of chemotherapy in INTERLACE .
We also tackle some of the apparent issues around INTERLACE.
Gemma has delivered a real tour de force on the INTERLACE trial and the background of cervical cancer treatment.
We hope you enjoy.
John & Mike